<?xml version="1.0" encoding="UTF-8"?>
<p>DBS has been used as an alternative method for diagnosis of viral [
 <xref rid="pone.0218353.ref003" ref-type="bibr">3</xref>–
 <xref rid="pone.0218353.ref005" ref-type="bibr">5</xref>], bacterial [
 <xref rid="pone.0218353.ref006" ref-type="bibr">6</xref>], fungal [
 <xref rid="pone.0218353.ref007" ref-type="bibr">7</xref>] and parasitic [
 <xref rid="pone.0218353.ref006" ref-type="bibr">6</xref>] infections. It has also been used to monitor HIV viral load and drug resistance in patients receiving antiretroviral therapy [
 <xref rid="pone.0218353.ref001" ref-type="bibr">1</xref>]. The DBS analysis platform is routinely used for estimation of DNA, protein and drugs [
 <xref rid="pone.0218353.ref008" ref-type="bibr">8</xref>–
 <xref rid="pone.0218353.ref011" ref-type="bibr">11</xref>] which have a great impact in clinical practice. DBS has been used for measuring immune responses after hepatitis A virus vaccination [
 <xref rid="pone.0218353.ref012" ref-type="bibr">12</xref>] with a positive agreement with plasma specimens. However, there is lack of information about the sensitivity of DBS to evaluate the immunogenicity in enteric infections.
</p>
